propranolol has been researched along with Tardive Dyskinesia in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Tardive Dyskinesia: Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the tolerability and effectiveness of propranolol in treating tardive dyskinesia (TD)." | 7.83 | Propranolol therapy for Tardive dyskinesia: A retrospective examination. ( Armstrong, KA; Factor, SA; Hatcher-Martin, JM; Scorr, LM, 2016) |
| " tardive dyskinesia) treatment with antipsychotics, including haloperidol, varies substantially among people." | 3.85 | Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms. ( Miksys, S; Nobrega, JN; Remington, G; Tolledo, EC; Tyndale, RF; Wadji, FB, 2017) |
| "To examine the tolerability and effectiveness of propranolol in treating tardive dyskinesia (TD)." | 3.83 | Propranolol therapy for Tardive dyskinesia: A retrospective examination. ( Armstrong, KA; Factor, SA; Hatcher-Martin, JM; Scorr, LM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, VD | 1 |
| Gupta, HV | 1 |
| Espay, AJ | 1 |
| Miksys, S | 1 |
| Wadji, FB | 1 |
| Tolledo, EC | 1 |
| Remington, G | 1 |
| Nobrega, JN | 1 |
| Tyndale, RF | 1 |
| Hatcher-Martin, JM | 1 |
| Armstrong, KA | 1 |
| Scorr, LM | 1 |
| Factor, SA | 1 |
3 other studies available for propranolol and Tardive Dyskinesia
| Article | Year |
|---|---|
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; D | 2020 |
Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Topics: Animals; Brain; Catalepsy; Cytochrome P450 Family 2; Haloperidol; Liver; Male; Microinjections; Nico | 2017 |
Propranolol therapy for Tardive dyskinesia: A retrospective examination.
Topics: Adrenergic beta-Antagonists; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propranolol | 2016 |